Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

NCT06550128 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: AHB-137
DRUG: AHB-137 and Placebo
DRUG: AHB-137 (16weeks)

Sponsor

Ausper Biopharma Co., Ltd.